Evidence map›Paper›PMID 29967602›Full record

ReviewFrontiers in immunology2018

Follicular CD4 T Helper Cells As a Major HIV Reservoir Compartment: A Molecular Perspective.

Malika Aid, Frank P Dupuy, Eirini Moysi, Susan Moir, Elias K Haddad, Jacob D Estes, Rafick Pierre Sekaly, Constantinos Petrovas, Susan Pereira Ribeiro

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 46 citations in OpenAlex.

  1. Unique CD8bioRxiv : the preprint server for biology · 2026
    Article
  2. HCV-specific CD4EBioMedicine · 2026
    Article
  3. Novel Approaches for Investigating Host Responses to HIV Infection in Ex Vivo Human Genital Tissues.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Cytotoxic CD4Frontiers in immunology · 2023
    Review
  12. Article
  13. HIV cure strategies: which ones are appropriate for Africa?Cellular and molecular life sciences : CMLS · 2022
    Review
  14. Article
  15. Article
  16. Cure and Long-Term Remission Strategies.Methods in molecular biology (Clifton, N.J.) · 2022
    Review
  17. Role of CXCR5Frontiers in microbiology · 2022
    Review
  18. Review
  19. Article
  20. T-Follicular-Like CD8Frontiers in immunology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Malika AidBeth Israel Deaconess Medical Center, Center for Virology and Vaccine Research, Harvard Medical School, Boston, MA, United States.
Frank P DupuyCentre hospitalier de l'Université de Montréal, Montreal, QC, United States.
Eirini MoysiTissue Analysis Core, Immunology Laboratory, Vaccine Research Center, NIH, Bethesda, MD, United States.
Susan MoirLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, United States.
Elias K HaddadDivision of Infectious Diseases & HIV Medicine, Department of Medicine, Drexel University College of Medicine, Philadelphia, PA, United States.
Jacob D EstesOregon National Primate Research Center, Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, United States.
Rafick Pierre SekalyPathology Department, Case Western Reserve University, Cleveland, OH, United States.
Constantinos PetrovasTissue Analysis Core, Immunology Laboratory, Vaccine Research Center, NIH, Bethesda, MD, United States.
Susan Pereira RibeiroPathology Department, Case Western Reserve University, Cleveland, OH, United States.
Case Western Reserve University · USBeth Israel Deaconess Medical Center · USCentre Hospitalier de l’Université de Montréal · CADrexel University · USNational Institute of Allergy and Infectious Diseases · USOregon Health & Science University · US

Funding

Role of B Lymphocytes In HIV Infection And PathogenesisZIAAI000825 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MOIR, SUSAN · 2009 to 2025
$24.5M
Defining HIV reservoirs that rebound following suspension of ARTR01AI134419 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI FRENKEL, LISA M, VANDEKERCKHOVE, LINOS · 2017 to 2021
$3.8M
Boosting anti-HIV immunity through manipulation of Tfh function.R01AI106482 · NIAID · VGTI FLORIDA · PI HADDAD, ELIAS K · 2013 to 2017
$2.8M
Targeting the IL-10 pathway for an HIV CureR21AI122380 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI SEKALY, RAFICK PIERRE · 2016 to 2017
$486k
NIAID NIH HHS R01 AI106482NIAID NIH HHS R01 AI134419NIAID NIH HHS R21 AI122380
6 · The paper itself

Abstract

Effective antiretroviral therapy (ART) has prevented the progression to AIDS and reduced HIV-related morbidities and mortality for the majority of infected individuals. However, a lifelong administration of ART is necessary, placing an inordinate burden on individuals and public health systems. Therefore, discovering therapeutic regimens able to eradicate or functionally cure HIV infection is of great importance. ART interruption leads to viral rebound highlighting the establishment and maintenance of a latent viral reservoir compartment even under long-term treatment. Follicular helper CD4 T cells (TFH) have been reported as a major cell compartment contributing to viral persistence, consequent to their susceptibility to infection and ability to release replication-competent new virions. Here, we discuss the molecular profiles and potential mechanisms that support the role of TFH cells as one of the major HIV reservoirs.

Indexed as

Anti-Retroviral AgentsDisease ProgressionHIV-1HIV InfectionsHumansLymph NodesT-Lymphocytes, Helper-InducerVirus LatencyVirus ReplicationAnti-Retroviral Agentscuregene expressionHIVlymph nodesTFH cell

Identifiers

PMID29967602
PMCPMC6015877
OpenAlexW2809359420

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.